Tags |
|
|
Links |
|
|
Advice You - Franchise Company Relation Strategies Considered
Franchise company relations are critical to meet market demands and
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
changes in customer or consumer buying behavior. Franchise relati
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ons between the franchisor and the franchised outlets or franchisee
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
s paramount to the success of the brand name. When franchise compa
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ny relation strategies are working smoothly this provides additiona
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
l efficiencies and therefore a greater chance for increased profits
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
for both the franchisor and the franchisee.
To maintain a strong
To maintain a strong
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ranchise company relations strategy there must be constant communic
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ation between both parties. There needs to be feedback from the fr
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
anchised outlets who are dealing with the customer on a constant an
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
d real-time basis. Any changes that the franchisor is considering
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
must be communicated to the franchisees in advance of any large cha
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
nge. Regional adaptation must also be considered in some markets,
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
as not all markets are created equal.
Franchise company relation s
Franchise company relation s
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
rategies must start from the very beginning even before the sale of
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
the franchise. There must be trust between both the franchisor an
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
d the franchisee and they need to work together in a common cause t
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
o win markets and increase the brand name recognition. When a fran
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
chise company is successful it is because of good communication and
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
good company relations strategy. Please consider all this in 2006
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/19295/adviceyou-Franchise-Company-Relation-Strategies-Considered.html">Franchise Company Relation Strategies Considered</a>
BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/19295/adviceyou-Franchise-Company-Relation-Strategies-Considered.html]Franchise Company Relation Strategies Considered[/url]
Related Articles:
Business Coach Explains To You How To Add Value
The Marvelous World of Metaphors
Bookmark it:
|